Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$774M |
| 2 |
Intuitive Surgical
ISRG
|
+$654M |
| 3 |
S&P Global
SPGI
|
+$464M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$326M |
| 5 |
CELG
Celgene Corp
CELG
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$591M |
| 2 |
Broadcom
AVGO
|
+$550M |
| 3 |
Monster Beverage
MNST
|
+$408M |
| 4 |
Booking.com
BKNG
|
+$377M |
| 5 |
McDonald's
MCD
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Healthcare | 15.49% |
| 4 | Financials | 12.97% |
| 5 | Communication Services | 11.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Southern Copper
SCCO
$145B
| $22.9M | 0.02% |
572,816
-43,628
| -7% | -$1.79M |
|
377
Travere Therapeutics
TVTX
$5.33B
| $22.8M | 0.02% |
794,319
-276,008
| -26% | -$7.89M |
|
378
Marathon Petroleum
MPC
$91.7B
| $22.7M | 0.02% |
284,130
-20,881
| -7% | -$1.65M |
|
379
Enbridge
ENB
$121B
| $22.5M | 0.02% |
697,847
+526,660
| +308% | +$18.4M |
|
380
Ovintiv
OVV
$17B
| $22.5M | 0.02% |
342,748
+18,003
| +6% | +$1.17M |
|
381
Rio Tinto
RIO
$158B
| $22.4M | 0.02% |
439,950
-759,908
| -63% | -$38.7M |
|
382
Puma Biotechnology
PBYI
$402M
| $22.4M | 0.02% |
488,418
-462,580
| -49% | -$22.3M |
|
383
Patterson-UTI
PTEN
$3.74B
| $22.2M | 0.02% |
1,298,852
-2,375,505
| -65% | -$40.8M |
|
|
ANDV
384
DELISTED
Andeavor
ANDV
| $22.1M | 0.02% |
144,010
-59,419
| -29% | -$8.77M |
|
385
Viatris
VTRS
$20.7B
| $22M | 0.02% |
602,131
-1,065,421
| -64% | -$40M |
|
386
Wingstop
WING
$3.66B
| $21.9M | 0.02% |
320,347
-362
| -0.1% | -$21.8K |
|
387
Verra Mobility
VRRM
$781M
| $21.7M | 0.02% |
+2,042,685
| New | +$21.1M |
|
|
CBIO
388
Crescent Biopharma
CBIO
$555M
| $21.6M | 0.02% |
14,988
-951
| -6% | -$1.44M |
|
|
NSA
389
DELISTED
National Storage Affiliates Trust
NSA
| $21.6M | 0.02% |
847,587
-374
| -0% | -$10.7K |
|
390
Cousins Properties
CUZ
$5.25B
| $21.6M | 0.02% |
606,012
-30,002
| -5% | -$1.12M |
|
391
Range Resources
RRC
$9.24B
| $21.5M | 0.02% |
1,265,619
-1,425
| -0.1% | -$22.9K |
|
392
Diageo
DEO
$49.5B
| $21.2M | 0.02% |
149,865
+1,826
| +1% | +$262K |
|
|
SRE.PRA
393
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $20.9M | 0.02% |
207,392
-733
| -0.4% | -$75.2K |
|
394
Goosehead Insurance
GSHD
$2.27B
| $20.9M | 0.02% |
616,063
-199,447
| -24% | -$5.78M |
|
395
Steel Dynamics
STLD
$36.2B
| $20.7M | 0.02% |
457,981
-33,778
| -7% | -$1.56M |
|
396
Spotify
SPOT
$107B
| $20.6M | 0.02% |
114,051
-51,357
| -31% | -$9.42M |
|
397
First Bancorp
FBNC
$2.61B
| $20.6M | 0.02% |
508,969
+74,434
| +17% | +$3.08M |
|
398
Dollar Tree
DLTR
$24.7B
| $20.6M | 0.02% |
252,197
-748,355
| -75% | -$65.7M |
|
399
Prestige Consumer Healthcare
PBH
$2.37B
| $20.4M | 0.02% |
538,944
-661
| -0.1% | -$25K |
|
|
ENLK
400
DELISTED
EnLink Midstream Partners, LP
ENLK
| $20.1M | 0.02% |
1,079,890
+646,808
| +149% | +$11.2M |
|
Similar funds
Jennison Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Jennison Associates held 739 positions worth $109B, up 5.9% from $103B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jennison Associates's Q3 2018 filing shows 86 new, 214 increased, 352 reduced and 81 closed positions. Its largest new stake was Tiffany & Co.: 1,169,094 shares worth $151M. The largest sale was FedEx, an estimated $591M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2018 buy was Tiffany & Co.: 1,169,094 shares worth $151M.
- Jennison Associates added most to AstraZeneca in Q3 2018, an estimated $774M increase.
- Jennison Associates's biggest Q3 2018 reduction was FedEx, cutting an estimated $591M.
- Jennison Associates fully exited Cheniere Energy Partners LP Holdings LLC in Q3 2018, selling an estimated $134M.
- Jennison Associates's ten largest holdings make up 30% of its $109B portfolio in Q3 2018.
- Jennison Associates opened 86 new positions and closed 81 in Q3 2018.
- Jennison Associates's portfolio value rose 5.9% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q3 2018, filed 8 Nov 2018.